India Interventional Cardiology Devices Market Overview, 2031

The interventional cardiology devices market in India is moving forward at a stable pace and is expected to continue expanding through 2031, mainly because heart related conditions are being diagnosed more frequently and patients are increasingly opting for minimally invasive treatment methods. A noticeable rise in lifestyle linked risk factors such as diabetes, stress, lack of physical activity, and unhealthy eating habits has contributed to a larger patient pool that requires angioplasty and other catheter based procedures, which in turn is supporting demand for stents, catheters, balloons, plaque modification devices, structural heart devices, and related accessories. Hospitals continue to handle the majority of procedures since they are better equipped with catheterization laboratories and trained specialists, yet specialty clinics and ambulatory surgical centers are gradually increasing their presence as shorter recovery times and planned day procedures become more common in urban areas. Coronary interventions account for a significant share of overall procedures because coronary artery disease remains one of the most common cardiac conditions in the country, while peripheral vascular interventions are also rising as awareness improves and diagnostic facilities become easier to access. Efforts to promote local manufacturing and regulate device pricing have helped improve affordability to some extent, allowing more patients to consider timely treatment. At the same time, differences in infrastructure quality between major cities and smaller districts, along with the limited availability of experienced interventional cardiologists in some regions, continue to affect overall adoption levels. Over the next several years, gradual improvements in hospital capacity, training programs, and availability of advanced devices are expected to strengthen procedural volumes and support a steady expansion of the market across both public and private health-care settings in India.


According to the research report, "India Interventional Cardiology Devices Market Outlook, 2031," published by Bonafide Research, the India Interventional Cardiology Devices Market is anticipated to grow at more than 9.38% CAGR from 2026 to 2031. The interventional cardiology devices market in India is evolving at a gradual but consistent pace, and its growth is strongly influenced by diagnosis trends, treatment affordability, and the pace at which hospitals upgrade their cardiac care capabilities. Over the past few years, a growing number of people have started opting for preventive health checkups, especially in urban and semi urban areas, which has helped in identifying heart related conditions at an earlier stage. Earlier detection often leads physicians to recommend catheter based procedures, and this has contributed to a steady increase in demand for interventional devices. Cost remains an important factor in the Indian health-care environment, as many patients still manage a portion of their treatment expenses themselves, so hospitals often look for devices that provide dependable clinical outcomes while remaining economically practical. In addition, rising health awareness through digital media and community screening camps has encouraged more individuals to seek medical advice before symptoms become severe, which is gradually improving procedural volumes. Another factor shaping market growth is the rising attention given to training programs and workshops, as hospitals recognize that well trained cardiologists and technicians are essential for performing complex procedures safely and efficiently. Expansion of private hospitals and cardiac centers into smaller cities is also improving access to interventional treatments, allowing more patients to receive care closer to home instead of traveling long distances. At the same time, procurement timelines in certain public sector facilities and differences in infrastructure quality across regions can influence how quickly new technologies are adopted. Overall, the industry is moving in a direction where steady capacity building, physician training, and balanced pricing strategies are becoming just as important as technological innovation in supporting long term market development in India.

Demand for interventional cardiology devices in India varies across product categories, but angioplasty stents continue to account for a large share of usage because they are routinely used in coronary procedures, which are among the most frequently performed cardiac interventions in the country. Drug eluting stents are widely preferred in many hospitals as they help reduce the chances of restenosis and are considered reliable for long term outcomes, which has strengthened their acceptance among cardiologists. Catheters also represent an essential segment since they are required in almost every interventional procedure, whether for diagnosis, guidance, or delivery of therapeutic devices, and hospitals maintain steady procurement cycles to ensure uninterrupted availability. In many tertiary care hospitals, catheter usage volumes remain high because a single complex procedure may require multiple catheter types for imaging, navigation, and device placement. Angioplasty balloons remain in consistent demand as well, particularly in centers that perform a high number of routine angioplasty procedures, while plaque modification devices are gradually gaining attention in complex cases where calcified lesions require specialized treatment approaches. Hemodynamic flow alteration devices, including support systems used in high risk interventions, are being adopted more selectively, mainly in advanced cardiac centers that handle complicated cases and have the required technical expertise. Structural heart devices are witnessing gradual growth as procedures for valve repair and other structural corrections become more common, especially in large urban hospitals where specialized cardiac teams are available. Other accessories, although smaller in individual value, form an important part of the overall market because they are required regularly during procedures and must be replenished frequently, ensuring a continuous baseline demand across health-care facilities in different regions of India.


From an application perspective, coronary interventions account for the highest number of interventional cardiology procedures in India, mainly because coronary artery blockages are one of the most common cardiac conditions treated in hospitals. Angioplasty is performed routinely in many cardiac centers, and the preference for minimally invasive procedures has increased because patients usually experience shorter recovery periods and reduced hospital stays, which makes these treatments more acceptable to a wide range of patients. This consistent procedural flow keeps the demand for stents, balloons, and guiding catheters stable across both large hospitals and mid sized cardiac units, where procedure volumes continue to rise gradually each year. In many urban cardiac centers, emergency angioplasty for acute cardiac events has also become more common, which further contributes to steady device utilization. Peripheral vascular interventions are also increasing step by step, particularly in patients suffering from diabetes related circulation problems and age related vascular disorders, where early treatment can help prevent serious complications and long term disability. Hospitals that previously handled only coronary cases are slowly expanding their infrastructure, equipment, and training programs to perform vascular interventions, which is helping this segment grow in a steady manner across several regions. The others category includes structural and less frequently performed interventional procedures, which are mainly carried out in advanced cardiac centers that have specialized teams, experienced cardiologists, and suitable imaging support to manage complex cases safely. Referral patterns between smaller clinics and larger hospitals have also improved over time, allowing complex cases to reach facilities that are equipped to manage them without unnecessary delays, which has gradually strengthened procedural coordination between different levels of health-care providers.


In India, interventional cardiology procedures are carried out through a mix of health-care settings, but hospitals remain the most active users of these devices because they are equipped to manage both routine angioplasty cases and complicated cardiac emergencies at any hour. Most tertiary care hospitals have fully functional catheterization laboratories and trained cardiac teams available, which allows them to perform a high number of procedures each month and maintain steady consumption of stents, balloons, catheters, and supporting accessories. Patients and referring physicians also tend to prefer hospitals when an intervention is required, as surgical backup and intensive monitoring are immediately available if complications arise, which gives both doctors and families greater confidence in treatment decisions. In addition, many large hospitals continue to expand their cardiac departments and upgrade procedure rooms, which further increases their capacity to handle interventional cases. Ambulatory surgical centers are gradually finding space in the treatment pathway, mainly in larger cities where selected low risk procedures can be scheduled in advance and completed within the same day, making them attractive for patients who want shorter stays and more predictable costs. Specialty clinics play a practical role in the overall system by handling consultations, diagnostic evaluations, and long term follow up, and they often guide patients toward suitable hospitals once an intervention becomes necessary. The others segment includes smaller private facilities and certain teaching institutions where procedures are performed occasionally, largely depending on visiting specialists or limited infrastructure. In many areas, improved coordination between diagnostic clinics, cardiologists, and hospitals has made it easier for patients to move from initial consultation to treatment without long waiting periods, which has gradually improved patient flow in several regional health-care networks.



Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031

Aspects covered in this report
• Interventional Cardiology Devices Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By product
• Angioplasty Stents
• Catheters
• Angioplasty Balloons
• Plaque Modification Devices
• Hemodynamic Flow Alteration Devices
• Structural Heart Devices
• Other Accessories

By Application
• Coronary Interventions
• Peripheral Vascular Interventions
• Others

By End User
• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics
• Others